Statins for Diabetic Cardiovascular Complications
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
245-251
Author(s):
Sora Ludwig and Garry X. Shen
Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
253-268
Author(s):
Eva Lonn and Jasmine Grewal
The Molecular Mechanisms of Vascular Restenosis: Which Genes are Crucial?
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
269-275
Author(s):
Jemma Bhoday, Sampath de Silva and Qingbo Xu
Facing Up the ROS Labyrinth - Where To Go?
Journal:
Current Vascular Pharmacology
Volume:
4
Page:
277-289
Author(s):
Armando Rojas, Hector Figueroa, Miguel A. Morales and Lamberto Re
Partnerships Between Philanthropy, Government and Investors are Needed to Advance Drug Discovery for Neurodegenerative Diseases
Journal:
Current Alzheimer Research
Volume:
3
Page:
175-176
Author(s):
Lorenzo M Refolo and Howard M Fillit
TGF-β Pathway as a Potential Target in Neurodegeneration and Alzheimers
Journal:
Current Alzheimer Research
Volume:
3
Page:
191-195
Author(s):
Tony Wyss-Coray
The Pharmacology of Aminoadamantane Nitrates
Journal:
Current Alzheimer Research
Volume:
3
Page:
201-204
Author(s):
Yuqiang Wang, Jerry Eu, Mark Washburn, Tong Gong, H.-S. Vincent Chen, W. Larrick James, Stuart A. Lipton, Jonathan S. Stamler, Gregory T. Went and Seth Porter
NO Chimeras as Therapeutic Agents in Alzheimers Disease
Journal:
Current Alzheimer Research
Volume:
3
Page:
237-245
Author(s):
Gregory R.J. Thatcher, Brian M. Bennett and James N. Reynolds
Fluorinated Molecules as Drugs and Imaging Agents in the CNS
Journal:
Current Topics in Medicinal Chemistry
Volume:
6
Page:
1457-1464
Author(s):
Shengguo Sun and Adeboye Adejare
Editorial [ NeuroAIDS: A Neuroscience Problem with Global Impact ]
Journal:
Current HIV Research
Volume:
4
Page:
245-247
Author(s):
Michael F. Nunn